TipRanks
Advertisement
Advertisement

JP:4516 Stock Latest News

Nippon Shinyaku Completes Treasury Share Disposal for Director Stock Compensation
Company AnnouncementsNippon Shinyaku Completes Treasury Share Disposal for Director Stock Compensation
2M ago
Nippon Shinyaku Delivers Strong Q1 Results and Confirms Stable Full-Year Outlook
PremiumCompany Announcements
Nippon Shinyaku Delivers Strong Q1 Results and Confirms Stable Full-Year Outlook
2M ago
Nippon Shinyaku Uses Restricted Stock to Tighten Director-Shareholder Alignment
PremiumCompany Announcements
Nippon Shinyaku Uses Restricted Stock to Tighten Director-Shareholder Alignment
3M ago
4516
Nippon Shinyaku Posts Revenue Growth but Lower Profit, Keeps Dividend Steady
PremiumCompany Announcements
Nippon Shinyaku Posts Revenue Growth but Lower Profit, Keeps Dividend Steady
5M ago
4516
NS-863 Phase 2 Trial Positions Nippon Shinyaku for a New Niche in Pulmonary Hypertension
PremiumCompany Announcements
NS-863 Phase 2 Trial Positions Nippon Shinyaku for a New Niche in Pulmonary Hypertension
7M ago
4516
Nippon Shinyaku’s NS-863 PAH Trial: Early-Stage Catalyst in a Competitive Specialty Market
PremiumCompany AnnouncementsNippon Shinyaku’s NS-863 PAH Trial: Early-Stage Catalyst in a Competitive Specialty Market
7M ago
4516
Nippon Shinyaku Revamps Board Lineup Ahead of June Shareholders’ Meeting
Premium
Company Announcements
Nippon Shinyaku Revamps Board Lineup Ahead of June Shareholders’ Meeting
8M ago
4516
Nippon Shinyaku Posts Higher Revenue but Lower Profit, Keeps Dividend Plan Intact
Premium
Company Announcements
Nippon Shinyaku Posts Higher Revenue but Lower Profit, Keeps Dividend Plan Intact
8M ago
4516
Nippon Shinyaku Reports Mixed Financial Results for H1 2025
PremiumCompany Announcements
Nippon Shinyaku Reports Mixed Financial Results for H1 2025
11M ago
4516
Nippon Shinyaku’s Promising DMD Study: What Investors Need to Know
PremiumCompany Announcements
Nippon Shinyaku’s Promising DMD Study: What Investors Need to Know
12M ago
4516
Nippon Shinyaku’s Promising Phase 2 Study for Duchenne Muscular Dystrophy
PremiumCompany Announcements
Nippon Shinyaku’s Promising Phase 2 Study for Duchenne Muscular Dystrophy
12M ago
4516
Nippon Shinyaku’s Promising Phase 2 Trial for Autoimmune Treatment
PremiumCompany Announcements
Nippon Shinyaku’s Promising Phase 2 Trial for Autoimmune Treatment
12M ago
4516
Nippon Shinyaku Completes Treasury Stock Disposal for Executive Compensation
PremiumCompany AnnouncementsNippon Shinyaku Completes Treasury Stock Disposal for Executive Compensation
1y ago
4516
Nippon Shinyaku Reports Q1 2025 Financial Results with Mixed Performance
Premium
Company Announcements
Nippon Shinyaku Reports Q1 2025 Financial Results with Mixed Performance
1y ago
4516
Nippon Shinyaku Implements Restricted Stock Compensation Plan
Premium
Company Announcements
Nippon Shinyaku Implements Restricted Stock Compensation Plan
1y ago
4516
Nippon Shinyaku Advances Corporate Governance and Diversity
PremiumCompany Announcements
Nippon Shinyaku Advances Corporate Governance and Diversity
2y ago
4516
Nippon Shinyaku Advances Corporate Governance
PremiumCompany Announcements
Nippon Shinyaku Advances Corporate Governance
2y ago
4516

Trending

Name
Price
Price Change
SPX
S&P 500
―
DJIA
Dow Jones
―
NDX
Nasdaq 100
―
More Trending Stocks >